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Abstract
Background: There is sufficient evidence to conclude that tobacco smoking is strongly linked to tuberculosis (TB)
and a large proportion of TB patients may be active smokers. In addition, a previous analysis has suggested that a
considerable proportion of the global burden of TB may be attributable to smoking. However, there is paucity of
information on the prevalence of tobacco smoking among TB patients in Malaysia. Moreover, the tobacco-related
knowledge, attitudes, and behaviors of TB patients who are smokers have not been previously explored. This study
aimed to document the prevalence of smoking among newly diagnosed TB patients and to learn about the
tobacco use knowledge and attitudes of those who are smokers among this population.
Methods: Data were generated on prevalence rates of smoking among newly diagnosed TB patients in the State
of Penang from January 2008 to December 2008. The data were obtained based on a review of routinely collated
data from the quarterly report on TB case registration. The study setting comprised of five healthcare facilities (TB
clinics) located within Penang and Wilayah Persekutuan, Kuala Lumpur health districts in Malaysia, which were
involved in a larger project, known as SCIDOTS Project. A 58-item questionnaire was used to assess the tobacco
use knowledge, attitudes and behaviors of those TB patients who were smokers.
Results: Smoking status was determinant in 817 of 943 new cases of TB from January to December 2008. Of
this, it was estimated that the prevalence rates of current- and ex-smoking among the TB patients were 40.27%
(329/817) and 13.95% (114/817), respectively. The prevalence of ever-smoking among patients with TB was
estimated to be 54,220 per 100,000 population. Of 120 eligible participants for the SCIDOTS Project, 88
responded to the survey (73.3% response rate) and 80 surveys were analyzed (66.7% usable rate). The mean (±
SD) total score of tobacco use knowledge items was 4.23 ± 2.66 (maximum possible score=11). More than half
of the participants (51.3%) were moderately dependent to nicotine. A moderately large proportion of the
respondents (41.2%) reported that they have ever attempted to quit smoking, while more than half (56.3%)
have not. Less than half (47.5%) of the study participants had knowledge about the body system on which
cigarette smoking has the greatest negative effect. The majority wrongly believed that smokeless tobacco can
increase athletic performance (60%) and that it is a safe and harmless product (46.2%). An overwhelming
proportion (>80%) of the patients believed that: smoking is a waste of money, tobacco use is very dangerous to
health, and that smokers are more likely to die from heart disease when compared with non-smokers. The use
of smokeless tobacco was moderately prevalent among the participants with 28.8% reporting ever snuffed, but
the use of cigar and pipe was uncommon.
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any medium, provided the original work is properly cited.Conclusion: Smoking prevalence rate is high among patients with TB in Malaysia. These patients generally had
deficiencies in knowledge of tobacco use and its health dangers, but had positive attitudes against tobacco use.
Efforts should be geared towards reducing tobacco use among this population due to its negative impact on TB
treatment outcomes.
Background
Tuberculosis (TB) and tobacco use are regarded as two
colliding epidemics of public health importance [1].
Recent estimates have shown that the two formidable
epidemics kill more than six million people worldwide
annually [2,3]. Furthermore, in recent years, there has
been a global explosion of interest on the association
between TB and exposure to tobacco smoke. Studies
have unequivocally documented consistent evidence that
smoking is associated with an increased risk of TB. Con-
siderable information exists on the risks of latent TB
infection, active disease and mortality from TB due to
tobacco smoking in many countries of the world [4-7].
In fact, these evidences are growing at an alarming rate.
For instance, three recent systematic reviews and meta-
analyses of observational studies have reaffirmed that
tobacco smoking is an important risk factor for being
infected with Mycobacterium tuberculosis, progression
to clinical disease and dying from TB [4-6]. These
reviews reported a pooled odds ratio (OR) of between
1.8 and 2.1 for latent TB infection; a relative risk (RR)
of about 1.6 for TB infection; a pooled OR of 2.6 for TB
disease and; a RR of 2.3-3.3 for TB disease for both cur-
rent- and ever-smokers [4-6]. Tobacco smoking has in
addition found to be significantly associated with treat-
ment failure, default, and relapse after successful TB
treatment [8-11].
In parallel, tobacco smoking has increased substan-
tially over the past few decades, in developing countries
where TB is co-prevalent with an estimated 930 million
of the world’s 1.1 billion smokers currently living in the
low-income and middle-income countries [12-14].
Furthermore, a large proportion of TB patients may be
active smokers or involuntarily exposed to other peo-
ple’s tobacco smoke [12,15-18]. A recent case-control
study from China reported a proportion of cigarette
smoking of 54.6% among TB patients, which was signifi-
cantly higher than that in the control group (45.1%)
with an adjusted OR of 1.93. With the overwhelming
and accumulating evidence of association between TB
and tobacco smoking, TB control programs might bene-
f i tf r o mi n t e g r a t e di n t e r v e n t i o n sa i m e da tr e d u c i n g
tobacco, especially among those at high risk [1,4,19].
Therefore, patients diagnosed with TB who are smokers
need to be aware of this association and the implications
of continued smoking on short- and long-term TB treat-
ment outcomes as well as future lung health. They also
need to be well-educated about tobacco use and its
health dangers in general as well as posses positive atti-
tudes towards reducing tobacco smoking. Understanding
the tobacco use literacy, attitudes and behaviors of
newly diagnosed TB patients is of paramount impor-
tance in individualizing smoking cessation intervention
via behavioral therapy and in designing effective educa-
tional intervention programs for the prevention of TB,
treatment failure, recurrence after successful treatment
and other poor outcomes.
Information on the prevalence rates of smoking
among TB patients in general and specifically in Malay-
sia is scarce. Moreover, the tobacco-related knowledge,
attitudes, and behaviors of TB patients who are smokers
have not been previously investigated. This study aimed
to determine the prevalence of smoking among newly
diagnosed TB patients and to evaluate the tobacco use
k n o w l e d g ea n da t t i t u d eo ft h o s ew h oa r es m o k e r s
among this population.
Methods
Prevalence of Smoking among Patients Newly Diagnosed
with TB
In this study, we generated data on smoking rates
among newly diagnosed TB patients for the State of
Penang in north Malaysia from January through Decem-
ber 2008. The data were obtained based on a review of
routinely collated data from the quarterly report on TB
case registration from various basic management units.
Clinicians working in government TB clinics in the
State of Penang were requested to routinely document
the smoking status of newly diagnosed TB patients
using pre-determined standard definitions, modified
from Centers for Disease Control (CDC). Current smo-
ker was defined as a patient who has smoked at least
100 cigarettes in his or her lifetime and who still smokes
daily or occasionally at the time of TB diagnosis or has
recently stopped within the period of experiencing the
current symptoms of respiratory illness. Ex-smoker was
defined as a person who reported smoking at least 100
cigarettes in lifetime, but has stopped at least one
month before experiencing the current symptoms of TB.
Current and ex-smokers were considered as ever smo-
kers (a person who has reported to have smoked at least
100 cigarettes in lifetime). Patients whose smoking sta-
t u sw a sn o td o c u m e n t e dw e r ee x c l u d e df r o mt h ea n a l y -
sis. For the estimation of the smoking rates among
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patients who fulfilled the definition of self-reported
smoking as above (ex- or current smoker), and the
denominator was the total number of patients in the
cohort whose self-reported smoking status was recorded
during TB diagnosis.
Tobacco Use Knowledge and Attitudes Survey among TB
Patients who Smoke
Study Area
The study area comprised of five healthcare facilities
(TB clinics): four centers located within Penang State
and one center in Wilayah Persekutuan Kuala Lumpur
health districts. The five clinics were involved in a larger
project, known as SCIDOTS Project. The larger project
was primarily intended to establish a value-added service
(delivery of smoking cessation intervention by TB-
DOTS providers) for patients with TB and to evaluate
its direct impact on the outcomes of tobacco cessation
and TB treatment.
Study Design and Population
This was a cross-sectional survey targeting all subjects
planned to be involved in an interventional study. The
study population included all the TB patients who were
current smokers at the time of TB diagnosis and who
were eligible and consented to be enrolled in the SCI-
DOTS Project. Both patients in the preparation stage of
behavior change (intervention group) and those in the
pre-contemplation/contemplation stage of behavior
change (control group) were approached to participate
in the survey on a voluntary basis.
Instrument
A 58-item questionnaire was used for the survey. The
questionnaire comprised of four sections: socio-demo-
graphic and smoking-related information (12 items),
knowledge of tobacco use (11 items), tobacco use atti-
tudes (18 items), and practice of tobacco use (17 items).
Multiple choice response format was used for the
knowledge questions, with one correct answer for each
question. In addition, the 18-item attitudes domain used
a five-point rating scale that indicated degrees of agree-
ment (strongly agree, agree, neutral, disagree, and
strongly disagree).
The questionnaire was initially developed in English
based on a study by Torabi et al. [20] and the Tobacco
Attitude Scale developed by Meier [21]. A panel of
experts in the field of public health and tobacco con-
trol reviewed the questionnaire for content and face
validity. Changes were made to clarify any ambiguity
and to ensure comprehension of the target population.
Standard forward and backward translation procedures
were used to develop a conceptually and culturally
equivalent Malay version of the questionnaire. The
translation committee comprised of the researchers
and two independent professional translators (natives
of Malay) who are fluent in both English and Malay.
The final reconciled version of the questionnaire in
Malay was produced and pilot tested among 20 smo-
kers before use in the survey. The reliability of the
knowledge and attitude domains of the survey instru-
ment was tested using Cronbach alpha technique. The
reliability coefficients of the two domains were 0.783
and 0.721, respectively.
Data Collection Procedures
The questionnaire was administered during the first visit
to TB clinic upon fulfillment of the eligibility criteria for
recruitment into the SCIDOTS Project and signing of
an informed consent. Participants were approached to
answer the questionnaire on voluntary basis. Participa-
tion in the survey was not a condition for enrollment in
the main project, but only subjects enrolled in the pro-
ject were required to participate in the survey. All sur-
vey participants were assured of anonymity and
confidentiality. Approval for the conduct of the study
was obtained from Medical Research Ethics Committee
(MREC) of the Ministry of Health, Malaysia.
Data Analysis
Data were stored in Microsoft Excel and subsequently
analyzed by using SPSS version 15.0 software package
(SPSS Inc., Chicago, IL). Exploration of the data was
performed prior to analysis to determine missing values
and the distribution (normality) of the variables. Both
descriptive and inferential statistics were applied wher-
ever appropriate. Descriptive statistics were used to
describe patients’ demographic information, knowledge,
attitudes and tobacco use behaviors. Knowledge on
tobacco use was evaluated using total score for each
participant, with one point for each correct answer and
zero points for each wrong answer; the possible score in
knowledge domain for each subject ranged from zero to
11. Student’s t-test and ANOVA test were applied to
determine demographic differences in knowledge among
the respondents.
Results
Prevalence of Smoking among Newly Diagnosed TB
Patients
There were 943 patients diagnosed with TB from Janu-
ary to December 2008 in the State of Penang. Of this,
the smoking status of 126 patients (13.36%) was not
documented by the clinicians; hence these patients were
excluded from the smoking prevalence estimations. The
rates of current-smoking and ex-smoking among the TB
patients were 40.27% (329/817) and 13.95% (114/817),
respectively. The prevalence of ever-smoking among
patients with TB was estimated to be 54,220 per
100,000 population. Figure 1 illustrates the smoking sta-
tus and rates of the newly diagnosed TB patients in the
Penang State.
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Demographic and Smoking-related Characteristics
Of the 120 patients enrolled in the SCIDOTS Project, 88
(73.33%) agreed to participate in the tobacco use KAP
survey. Of this, 80 surveys were included in the data
analysis (usable rate of 66.67%). Table 1 provides the
socio-demographic characteristics of the study respon-
dents. Of the 80 participants, 56 (70.0%) were Malay, 18
(22.5%) were Chinese, and only four (5.0%) were Indian.
The respondents were predominantly male (98.7%),
which reflects the low smoking rate among female in
Malaysia. Nearly 61.3% of the patients were 42 years or
older at the time of recruitment into the study.
Furthermore, a huge proportion (80%) of the respon-
dents was either privately- or self-employed and the
majority (59%) lived in urban or semi-urban areas.
When asked to rate their health status, nearly 40% of
the TB patients who smoke rated themselves as
‘unhealthy’ or ‘very unhealthy’, while 45.6% believed
that they were ‘average’. The respondents were further
asked about their perception of stress of daily life and
nearly half (48.1%) perceived daily life as not too
stressful.
The majority of the participants (78.5%) reported
that they were in support of the on-going Malaysian
government’s campaigns against tobacco use (e.g.,”Tak
Nak“ or “Don’tW a n t ” program), whereas a marginal
proportion (3.8%) was not. In addition, nearly one
third (32.9%) of the smoking TB patients believed that
the tobacco industry was truthful to the Malaysian
people on the health dangers of tobacco use, whereas
an equal percentage of the respondents had a contrary
opinion.
Thirteen (16.3%) and 22 (27.5%) of the respondents
reported that they started smoking at the age of 13
years or younger and 14-15 years, respectively. The
study found that only 18.8% of the participants picked
Figure 1 Prevalence of Smoking among Patients with TB in Penang State, Malaysia (January - December 2008).
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older). When the nicotine dependence of the patients
was measured using Fagerström Test for Nicotine
Dependence (FTND) [22], more than half (51.3%) were
moderately dependent (score of 4 - 6) and more than
one-fourth (27.5%) were highly dependent on nicotine
(score of 7 - 10). Furthermore, a moderately large pro-
portion of the respondents (41.2%) reported that they
have ever attempted to quit smoking, while more than
half (56.3%) have not. On the other hand, a marginal
proportion of 2.5% had previously been abstinent for
more than six months. We further assessed the current
stage of behavior change of the respondents using the
transtheoretical model of change [23]. Half (50%) of
them were in the preparation stage (willing and ready to
quit within the next 30 days), while the remaining half
were in either contemplation stage (considering quitting
w i t h i nt h en e x t6m o n t h sb u tn o ti nt h en e x t3 0d a y s )
or precontemplation stage (not thinking about quitting
within the next 6 months). Additional details on the
smoking-related characteristics of the study participants
are presented in Table 2.
Tobacco Use Knowledge Scores among TB Patients who
Smoke
Table 3 shows the proportions of the respondents who
answered each item of tobacco use knowledge correctly.
Less than half (47.5%) of the study participants had
knowledge about the body system on which cigarette
smoking has the greatest negative effect and slightly
more than half (52.5%) understood the reason why smo-
ker’s heart works harder than that of non-smoker. In
addition, only 35% correctly recognized that smokers get
tired easily due to inability of their lungs to exchange
gases effectively. Also, the majority wrongly believed
that smokeless tobacco (snuff) can increase athletic per-
formance (60%) and that it is a safe and harmless pro-
duct (46.2%).
Furthermore, only one-fourth of the respondents were
able to recognize the dose-response relationship
between smoking and related diseases. However, at least
60% of the participants knew that smokers are less likely
to live as long as non-smokers and that chronic bron-
chitis in smokers is caused by irritation of the respira-
tory system and the chemicals in cigarettes (Table 3).
The mean (± SD) total score of tobacco use knowl-
edge items was 4.23 ± 2.66. The influence of demo-
graphic and smoking-related characteristics on tobacco
use knowledge was further tested using inferential statis-
tics. Overall, the knowledge differed significantly with
previous quit attempt, stage of change and ethnic
groups (Table 4). Patients who were in the stage of con-
templation/pre-contemplation had significantly less
knowledge than those in the preparation stage of change
(3.73 vs. 5.38; p=0.004). A similar trend was observed
among those who had been abstinent for more than six
months when compared with those who had never
attempted quitting smoking.
Tobacco Use Attitudes of TB Smokers
The tobacco use attitudes of the study population were
evaluated using an 18-item scale (Table 5). Notably,
Table 1 Socio-demographic characteristics of the newly
diagnosed TB patients who smoke (N = 80)
Characteristic n (%)
Gender
Male 79 (98.7%)
Female 1 (1.3%)
Age
18-25 years 10 (12.5%)
26-33 years 12 (15.0%)
34-41 years 9 (11.3%)
42-49 years 14 (17.5%)
≥50 years 35 (43.8%)
Race
Malay 56 (70.0%)
Chinese 18 (22.5%)
Indian 4 (5.0%)
Others 2 (2.5%)
Occupation
Government 4 (5.0%)
Private 35 (43.8%)
Self-employed 29 (36.2%)
Others 12 (15.0%)
Living environment
An urban area 35 (44.9%)
A suburban area 11 (14.1%)
A small town 31 (39.7%)
A rural area 1 (1.3%)
Health status perception
Very healthy 0 (0.0%)
Healthy 12 (15.2%)
Average 36 (45.6%)
Unhealthy 30 (38.0%)
Very unhealthy 1 (1.3%)
Daily life perception
Very stressful 4 (5.1%)
Somewhat stressful 31 (39.2%)
Not too stressful 38 (48.1%)
Not stressful at all 6 (7.6%)
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and a similar proportion believed that it calms nerves
(61.3%). Many respondents (70.1%) also agreed or
strongly agreed that smoking makes them relieve all life
stresses. However, an overwhelming proportion of the
patients agreed or strongly agreed that: smoking is a
waste of money (87.5%); tobacco use is very dangerous
to health (91.3%) and; smokers are more likely to die
from heart disease when compared with non-smokers
(81.3%).
In addition, the vast majority had a positive attitude
that: sales of cigarettes should be outlawed (91.3%), peo-
ple below the age of 18 years should be restricted from
purchasing cigarettes (95.1%), and smoking should be
allowed at fewer places than it were (63.8%). Conversely,
many respondents were neutral on the point that smok-
ing keeps ones weight down (41.3%) and the belief that
it gives confidence (45.0%).
Tobacco Use Behaviors among the Respondents
The pattern of tobacco products used among the parti-
cipants is shown in Table 6. All the respondents had
ever smoked cigarettes and admitted to annual cigarette
smoking. Only one of them denied monthly cigarette
smoking. The use of snuff was moderately prevalent
Table 2 Smoking-related characteristics of the newly
diagnosed TB patients who smoke (N = 80)
Characteristic n (%)
Support the on-going government
campaigns against tobacco use - e.g.,
“Tak Nak” program
Yes 62
(78.5%)
No 3
(3.8%)
Not sure 14
(17.7%)
Truthfulness of tobacco industry to
Malaysian people with regards to the
serious health consequences of tobacco
use
Yes 26
(32.9%)
No 26
(32.9%)
Not sure 27
(34.2%)
Age of first time cigarette use
≤13 years 13
(16.3%)
14-15 years 22
(27.5%)
16-17 years 11
(13.8%)
18-19 years 19
(23.8%)
≥20 years 15
(18.8%)
Fagerström Test for Nicotine
Dependence (FTND)
High (7-10) 22
(27.5%)
Moderate (4-6) 41
(51.3%)
Minimal (<4) 17
(21.3%)
Previous quitting smoking attempt
Have ever tried quitting smoking 33
(41.2%)
Have been abstinent for more than 6
months
2
(2.5%)
Have not tried quitting smoking before 45
(56.3%)
Current stage of behavior change
Preparation 40
(50.0%)
Pre-contemplation or contemplation 40
(50.0%)
Table 3 Items measuring tobacco use knowledge among
TB patients who smoke (N = 80)
a
Knowledge Item n (%) correct
responses
Smoking has the greatest negative effect on the
vascular system.
38 (47.5%)
A smoker’s heart works harder because carbon
monoxide makes the blood carry less oxygen.
42 (52.5%)
Nicotine, an ingredient in cigarette smoke, is both
stimulating and depressing to the nervous
system.
11 (13.8%)
Cigarette smokers get tired easily because their
lungs cannot exchange gas well.
28 (35.0%)
The person most likely to get lung cancer is pipe
smoker.
3 (3.8%)
Cigarette smokers are more likely to not live as
long as non-smokers.
48 (60.0%)
The “smoker’s cough”, a type of chronic
bronchitis is caused by irritation of the lungs and
bronchial tubes and due to the chemicals in the
cigarette.
54 (67.5%)
The dangers from cigarette smoking increase
with dose (number of cigarettes smoked, number
of years a person smoked, and amount of smoke
inhaled).
20 (25.0%)
Smokeless tobacco is a safe, harmless product. 43 (53.8%)
Using chewing tobacco can lead to oral cancer. 48 (60.0%)
Using smokeless tobacco can increase athletic
performance.
32 (40.0%)
aEleven tobacco use knowledge items (total score of the participants ranged
from 0 - 8)
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reporting ever snuffed. Of this, 17 (73.9%) and 14
(60.9%) reported annual and monthly snuffing, respec-
tively. However, the use of cigar and pipe was uncom-
mon among the study population (Table 6).
The study found that a higher proportion of the
respondents started smoking cigarettes at younger age
when compared with smokeless tobacco use (Table 7).
The same patter holds true for other tobacco products.
For instance, 7 of 8 (87.5%) cigar users and all 3 users
of pipe (100%) started the behavior at the age of 20
years or older. The smoking initiation age for various
tobacco products among the participants is presented in
Table 7.
Discussion
In addition to the collision between TB and tobacco epi-
demics in many developing nations, the prevalence of
smoking among patients with TB is generally high
[17,19]. Previous studies suggest that a large proportion
Table 4 The influence of patient’s characteristics on
tobacco use knowledge
Characteristic Mean ± SD of
knowledge
p-value
a
Overall mean 4.23 ± 2.66 (Range 0 - 8)
Age
18-25 years 5.00 ± 2.40
26-33 years 3.00 ± 2.37
34-41 years 5.67 ± 2.29 0.079
42-49 years 5.43 ± 2.47
≥50 years 4.31 ± 2.63
Race
Malay 5.11 ± 2.38
Chinese 2.94 ± 2.49 0.016
Indian 4.50 ± 2.52
Others 3.50 ± 4.95
Occupation
Government 6.00 ± 1.63
Private 4.51 ± 2.49 0.289
Self-employed 4.03 ± 2.85
Others 5.42 ± 2.23
Living environment
An urban area 4.00 ± 2.93
A suburban area 4.91 ± 2.47
A small town 5.13 ± 2.06 0.299
A rural area 6.00
Marital status
Married 4.90 ± 2.66
Single 4.19 ± 2.30 0.355
Divorced 3.50 ± 3.33
Others 7.00
Health status perception
Very healthy 0
Healthy 2.92 ± 3.09
Average 5.08 ± 2.62 0.095
Unhealthy 4.57 ± 2.18
Very unhealthy 4.00
Daily life perception
Very stressful 4.25 ± 3.10
Somewhat stressful 4.97 ± 2.14 0.061
Not too stressful 3.89 ± 2.83
Not stressful at all 6.67 ± 1.75
Support the on-going government campaigns against tobacco use
Yes 4.63 ± 2.65
No 3.00 ± 1.00 0.574
Not sure 4.50 ± 2.59
Truthfulness of tobacco industry to Malaysian people with regards
to the health consequences of tobacco
Yes 4.27 ± 2.78
No 5.42 ± 2.34 0.098
Not sure 3.96 ± 2.52
Age of first time cigarette
use
≤13 years 3.85 ± 2.48
14-15 years 5.32 ± 2.26
16-17 years 3.55 ± 2.81 0.328
18-19 years 4.58 ± 2.61
≥20 years 4.73 ± 2.84
Fagerström Test for Nicotine Dependence (FTND)
High (7-10) 4.55 ± 2.50
Moderate (4-6) 4.10 ± 2.60 0.114
Minimal (<4) 5.65 ± 2.45
Previous quitting smoking attempt
Have ever tried quitting 4.18 ± 2.71
Have been abstinent for
more than 6 months
7.50 ± 2.12 0.018
Have not tried quitting
before
4.69 ± 2.45
Stage of change
Preparation 5.38 ± 2.12 0.004
b
Pre-contemplation or
contemplation
3.73 ± 2.76
aOne way ANOVA was applied;
bIndependent t-test was used
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rily exposed to other people’s tobacco smoke
[12,15-18,24]. In the present study, we found that smok-
ing prevalence rate was high among patients with TB in
the State of Penang (current and ex-smoking rates of
40.27% and 13.95%, respectively). This rate is as high as
those reported from other countries (35 - 86%)
[12,15,18,24-26]. Although the smoking rate in the cur-
rent study is higher than the national average among
the general adult population (21.5%), but it was
somewhat lower than the male smoking rate in Malaysia
(46.4%) [27]. Our findings may largely reflect smoking
rate among male TB patients, since they predominated
the study population. However, the rates in our study
might have been grossly underestimated due to the
unknown smoking status of a reasonable proportion of
the newly diagnosed TB pati e n t sw h om i g h ta sw e l lb e
tobacco smokers. Furthermore, since we used self-
reported smoking status, it is possible that the rates
might have been under-recorded, which would mean
that the prevalence of smoking among patients with TB
would be even greater than observed. A systematic
review has demonstrated a trend of underestimation
when smoking prevalence is based on self-reports [28].
One study from three West Africa countries (Guinea,
G u i n e aB i s s a u ,a n dT h eG a m b i a )r e p o r t e dt h a tt h e
smoking prevalence rate among TB cases was twice as
high as among control household members (35% versus
17%, respectively) [15]. In India, the prevalence of smok-
ing was 3.5 times as high among patients with TB com-
pared with controls (86% versus 24%) [12].
Therefore, efforts should be geared towards reducing
tobacco use among this population due to its negative
impact on TB treatment outcomes. In the light of the
burden of TB association with tobacco smoking, patients
need to be well-educated about tobacco use and its
health dangers. They also need to have positive attitudes
Table 5 Attitudes of newly diagnosed TB patients towards tobacco use (N = 80)
Attitude Item Degree of Response
Strongly
Disagree, n (%)
Disagree, n
(%)
Neutral, n
(%)
Agree, n (%) Strongly
Agree, n (%)
Smoking is fun. 3 (3.8%) 14 (17.5%) 11 (13.8%) 45 (56.3%) 7 (8.8%)
People smoke just to show off. 4 (5.0%) 23 (28.8%) 17 (21.3%) 30 (37.5%) 6 (7.5%)
Smoking calms your nerves. 2 (2.5%) 16 (20.0%) 13 (16.3%) 44 (55.0%) 5 (6.3%)
Smoking makes you smelly. 2 (2.5%) 6 (7.5%) 9 (11.3%) 49 (61.3%) 14 (17.5%)
Smoking makes you look tough. 3 (3.8%) 23 (28.8%) 25 (31.3%) 23 (28.8%) 6 (7.5%)
Smoking is a waste of money. 1 (1.3%) 3 (3.8%) 6 (7.5%) 34 (42.5%) 36 (45.0%)
Smoking makes you relieve all life stresses. 2 (2.5%) 6 (7.5%) 16 (20.0%) 49 (61.3%) 7 (8.8%)
Smoking keeps your weight down. 3 (3.8%) 7 (8.8%) 33 (41.3%) 32 (40.0%) 5 (6.3%)
Smoking gives you confidence. 3 (3.8%) 14 (17.5%) 36 (45.0%) 23 (28.8%) 4 (5.0%)
Smoking should be allowed at fewer places than it is now. 0 (0%) 10 (12.5%) 19 (23.8%) 41 (51.3%) 10 (12.5%)
Smoking is very dangerous to your health. 0 (0%) 1 (1.3%) 6 (7.5%) 35 (43.8%) 38 (47.5%)
Sales of cigarettes should be outlawed. 0 (0%) 1 (1.3%) 6 (7.5%) 47 (58.8%) 26 (32.5%)
People under 18 buying cigarettes should be restricted by
law.
0 (0%) 3 (3.8%) 1 (1.3%) 35 (43.8%) 41 (51.3%)
Smoking gives you bad breath. 0 (0%) 3 (3.8%) 3 (3.8%) 43 (53.8%) 31 (38.8%)
Smokers are more likely to die from heart disease than
non-smokers.
0 (0%) 3 (3.8%) 12 (15.0%) 41 (51.3%) 24 (30.0%)
It is okay to smoke if you don’t get in the habit. 0 (0%) 11 (13.8%) 21 (26.3%) 40 (50.0%) 8 (10.0%)
Sharing cigarettes can act as an “ice breaker”. 2 (2.5%) 14 (17.5%) 19 (23.8%) 35 (43.8%) 10 (12.5%)
Smoking together may lead to friendship. 3 (3.8%) 15 (18.8%) 21 (26.3%) 30 (37.5%) 11 (13.8%)
Table 6 Practice and pattern of tobacco products use
among TB patients (N = 80)
Tobacco product use n (%)
Ever smoked cigarettes 80 (100%)
Annual cigarettes smoking 80 (100%)
Monthly cigarettes smoking. 79 (98.8%)
Ever snuffed 23 (28.8%)
Annual snuffing 17 (21.3%)
Monthly snuffing 14 (17.6%)
Ever smoked cigars (tobacco) 8 (10.0%)
Annual cigar uses/smoking 5 (6.3%)
Monthly cigar uses/smoking 3 (3.8%)
Ever smoked a pipe (tobacco) 3 (3.8%)
Annual pipe uses 3 (3.8%)
Monthly pipe uses 2 (2.5%)
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Page 8 of 10against tobacco smoking. Malaysian government has
initiated mass media campaigns against tobacco use
under the “Tak Nak“ or “Don’tW a n t ” program. Yet
substantial proportions of TB patients in the current
study were either not sure or did not support the on-
going government campaigns against tobacco use.
Understanding the tobacco use knowledge, attitudes
and behaviors of TB patients is of significance in the
provision of behavioral therapy for smoking cessation.
In a cross-sectional study among former TB patients in
Indonesia, more than 30% of them reported that they
were never asked about their smoking behavior or
advised about quitting [26]. Such information will also
be of value in designing effective educational interven-
tion programs on motivating tobacco users to quit and
urging non-users to avoid smoking. The educational
programs can have an impact in the control and preven-
tion of TB, treatment failure, relapse and poor prog-
nosis. The mean total score of tobacco use knowledge
of 4.23 (equivalent to 38.5%) found in this study sug-
gests that newly diagnosed TB patients had poor knowl-
edge of tobacco use. Although, the knowledge tested in
the current study was about tobacco use and its health
consequences in general, this finding points to possible
deficits in knowledge specific to the association between
tobacco smoke exposure and TB. Two recent studies
conducted among ex-TB patients reported that the
majority received only general health messages and not
TB-specific messages [24,26]. Such subjects seem to be
ill-informed about the impact of continued smoking on
TB. Therefore educational programs specific to the
impact of tobacco smoke exposure on TB should be
designed to educate TB patients who are smokers on
the general health dangers of tobacco use as well as its
negative impacts on TB. They should also be enligh-
tened on the short- and long-term benefits of quitting
smoking on TB treatment outcomes and future lung
health. In the present study, patients in the stage of pre-
paration for behavior change were significantly more
knowledgeable than their counterparts who were still in
the contemplation and pre-contemplation stages (5.38
vs. 3.73, respectively). Perhaps this reaffirms that their
intention to quit may be associated with the knowledge
they possessed. Those who had previous quitting experi-
ence also seemed to be more knowledgeable than their
counterparts who had never attempted to do so.
In general the patients had positive attitudes against
t o b a c c ou s e .T h e s ef i n d i n g sa r ee n c o u r a g i n g .F o r
instance, the respondents generally believed that tobacco
smoking is a waste of money and is very dangerous to
health. They also admitted that the sales of cigarettes
should be outlawed, people under 18 years of age should
be restricted from buying cigarettes and that smoking
should be allowed at fewer places than it were. In this
study, the use of cigar, pipe, and smokeless tobacco
(snuff) was not prevalent among TB patients who
smoke cigarettes. Furthermore, most of the respondents
started the behavior of using tobacco products other
than cigarettes at the age of 20 years and above. This
indicates that intervention programs on prevention of
tobacco use should target younger age groups.
This study has a number of limitations. First, the
tobacco use behaviors of patients with TB may be
under- or over-estimated in the light of using self-
reports without biochemical verifications. Secondly, the
sample may not be representative of all TB patients who
are smokers in Malaysia, since it was derived from only
two states. Lastly, the evaluation of knowledge did not
include items specific to the negative impact of tobacco
smoking on TB.
Conclusion
Smoking prevalence among patients with TB in Malay-
sia was as high as those reported from other countries
of the world. These patients generally had deficiencies
in knowledge of tobacco use and its health dangers. In
Table 7 Age of first-time use of various tobacco products
among TB smokers (N = 80)
Age of first time use n (%)
Cigarette use
≤13 years 13 (16.3%)
14 - 15 years 22 (27.5%)
16 - 17 years 11 (13.8%)
18 - 19 years 19 (23.8%)
≥20 years 15 (18.8%)
Snuff or smokeless tobacco use
≤13 years 0 (0%)
14 - 15 years 1 (1.3%)
16 - 17 years 3 (3.8%)
18 - 19 years 5 (6.3%)
≥20 years 13 (16.3%)
Cigar use
≤13 years 0 (0%)
14 - 15 years 0 (0%)
16 - 17 years 1 (1.3%)
18 - 19 years 0 (0%)
≥20 years 7 (8.8%)
Tobacco pipe use
≤13 years 0 (0%)
14 - 15 years 0 (0%)
16 - 17 years 0 (0%)
18 - 19 years 0 (0%)
≥20 years 3 (3.8%)
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Page 9 of 10general, the study has managed to contribute additional
information regarding the prevalence of smoking among
newly diagnosed TB patients and their tobacco-use
knowledge and attitudes. The results give cause for a
great concern about the deficit in knowledge among TB
patients who are smokers. Comprehensive tobacco edu-
cation and smoking cessation programs should be
aggressively promoted in TB settings.
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